Robert Paull

Co-Founder and Venture Partner·Lux Capital

Bio

Professional summary

Robert Paull is Co-Founder and Venture Partner at Lux Capital, focused on healthcare. He manages Lux investments in Cala Health, Kala Pharmaceuticals, Kyruus, and Visterra, and his previous investments include Cerulean Pharmaceuticals, Magen Biosciences, and Molecular Imprints. He was founding CEO of Harvard Medical School spinout Genocea Biosciences and Johns Hopkins spinout Kala Pharmaceuticals, and he co-founded Lux Research.

Notable companies

Selected portfolio companies the partner has backed

Cala HealthKala PharmaceuticalsKyruusVisterraCerulean PharmaceuticalsMagen BiosciencesMolecular Imprints

Background

Career, education, and skills

Career history

Lux CapitalCo-Founder and Venture PartnerPresent
Lux ResearchCo-Founder
Kala PharmaceuticalsFounding CEO
Genocea BiosciencesFounding CEO

Education

University of VirginiaBS

Other partners at Lux Capital

12 more profiles

View firm →

Bilal Zuberi

Co-President & General Partner

Lux Capital

Bilal Zuberi is associated with Lux Capital as a long-time deeptech investor. Public profiles describe more than a decade as a Lux General Partner, with investments across applied AI, autonomy, industrial technology, hardware, climate, healthcare and other technically ambitious sectors.

DeeptechHardwareIndustrial AI

Brandon Reeves

Partner

Lux Capital

Lux partner investing in AI, software, defense, manufacturing and robotics.

Artificial intelligenceAutonomous systemsDefenseManufacturingRoboticsSoftware

Danny Crichton

Partner, Research

Lux Capital

Lux Partner, Research and editor-in-chief, formerly managing editor at TechCrunch.

FinanceMediaResearchRiskgamingScienceTechnology analysis

David K. Yang

Partner

Lux Capital

Lux life sciences partner focused on therapeutics, R&D tools and biopharma infrastructure.

Biopharma infrastructureBiotechLife sciencesR&D toolsTherapeutics

Deena Shakir

Partner

Lux Capital

Deena Shakir is a Partner at Lux Capital. Her official profile says she invests across stages and sectors, including women's health, digital health infrastructure, health equity, foodtech, and fintech.

Digital health infrastructureFintechFoodtechWomen's health

Firas Atwa

Lux Capital

Harvard MBA candidate with prior Algebra Ventures, Swvl, and Alvarez & Marsal experience.

AfricaEmerging marketsEntrepreneurshipFintechStrategyVenture capital

Grace Isford

Partner

Lux Capital

Lux partner investing in computational sciences, AI applications, and infrastructure software.

AIComputational sciencesInfrastructure softwareLLM applicationsPhysical-world software

Josh Wolfe

Partner and Co-Founder

Lux Capital

Josh Wolfe is Partner and Co-Founder at Lux Capital. His official profile says he helps lead the firm, invests in defense and biotech, and has co-founded more than 20 Lux companies.

AIBiotechRoboticsSpace

Lan Jiang

Partner

Lux Capital

Lux partner focused on biotech analytics, ML infrastructure, developer tooling, and AI applications.

AI applicationsBiotech analyticsDeveloper toolingHealthcareMachine learning infrastructurePlatform therapeutics

Laurence Pevsner

Partner, Research

Lux Capital

Lux research partner focused on media, pedagogy, Riskgaming, and science-policy communication.

Editorial partnershipsPublic policyResearchRiskgamingScience communicationStrategic messaging

Peter Hébert

Partner and Co-Founder

Lux Capital

Peter Hébert is Partner and Co-Founder at Lux Capital. His official profile says he helps lead the firm, invests across technology and healthcare, and launched Lux's Health + Tech investment strategy.

DeeptechFrontier technology

Shahin Farshchi

Partner

Lux Capital

Lux partner investing across AI, semiconductors, autonomy, aerospace, and frontier tech.

AerospaceAIAutonomyCompany formationFrontier technologySemiconductors